Peptide Protocol Series
MOTS-c Peptide Protocol
Safe GLP-1 Alternative · 16-Week Progressive Program
For patients who cannot use GLP-1 medications
A 16-week progressive MOTS-c protocol for patients who cannot use GLP-1 medications due to thyroid cancer family history or other contraindications. Gradually retrains your metabolism from the inside out — fat burning, cortisol reduction, and inflammation relief.
Instant PDF download · Clinical reference document
What MOTS-c Does
Metabolic Reset from the Inside Out
The Protocol
Four Phases. 16 Weeks.
Foundation Phase
Low-dose introduction to allow receptor acclimation, baseline metabolic assessment, and tolerance evaluation.
Activation Phase
Dose escalation targeting AMPK activation, fat oxidation upregulation, and insulin sensitivity improvement.
Optimization Phase
Peak protocol phase with full metabolic and anti-inflammatory benefits. Body composition changes become measurable.
Maintenance Phase
Consolidation of results, cortisol stabilization, and planning for cycling or long-term maintenance dosing.
Get the Protocol
Instant Digital Access
MOTS-c Peptide Protocol™
Instant digital download · PDF format · Yours forever
- 16-Week Progressive Protocol (full PDF)
- Week-by-Week Dosing Schedule
- Phase Breakdown with Goals & Milestones
- Expected Timeline to Results
- Cortisol & Stress Resilience Protocol
- Insulin Sensitivity Optimization Guide
- Peptide Pairing Recommendations
- Lifestyle & Nutrition Amplifiers
- Lifetime access + all future updates
🔒 Secure checkout via Stripe · Instant PDF delivery
This protocol is intended for use under clinical supervision. All dosing decisions should be individualized based on patient history, labs, and provider assessment. MOTS-c is not FDA-approved as a therapeutic agent.
